Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Depletion of Fumarate Hydratase, an Essential TCA Cycle Enzyme, Drives Proliferation in a Two-Step Model. | Cancers (Basel) | 2022 | 36428601 | PubTator, text mining | PubMed |
| Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells. | Cell Death Discov | 2022 | 36424385 | PubTator, text mining | PubMed |
| Workforce Considerations When Building a Precision Medicine Program. | J Pers Med | 2022 | 36422106 | PubTator, text mining | PubMed |
| Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression-Arguments for Preemptive Testing. | J Xenobiot | 2022 | 36412766 | PubTator, text mining | PubMed |
| Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution. | ACS Pharmacol Transl Sci | 2022 | 36407958 | PubTator, text mining | PubMed |
| Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma. | Front Cell Dev Biol | 2022 | 36407113 | PubTator, text mining | PubMed |
| Multi-omics to predict changes during cold pressor test. | BMC Genomics | 2022 | 36402977 | PubTator, text mining | PubMed |
| Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments. | ANZ J Surg | 2022 | 36398349 | PubTator, text mining | PubMed |
| Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB. | Front Med (Lausanne) | 2022 | 36388934 | PubTator, text mining | PubMed |
| The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. | Cell Rep | 2022 | 36384132 | PubTator, text mining | PubMed |
| The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells. | Int J Mol Sci | 2022 | 36361992 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. | Cancers (Basel) | 2022 | 36358854 | PubTator, text mining | PubMed |
| Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives. | Cancers (Basel) | 2022 | 36358791 | PubTator, text mining | PubMed |
| Rare and common genetic determinants of metabolic individuality and their effects on human health. | Nat Med | 2022 | 36357675 | PubTator, text mining | PubMed |
| Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation. | Pharmaceuticals (Basel) | 2022 | 36355560 | PubTator, text mining | PubMed |
| Drug-Drug-Gene Interactions in Cardiovascular Medicine. | Pharmgenomics Pers Med | 2022 | 36353710 | PubTator, text mining | PubMed |
| Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients. | Front Oncol | 2022 | 36353538 | PubTator, text mining | PubMed |
| Spatially resolved gene regulatory and disease-related vulnerability map of the adult Macaque cortex. | Nat Commun | 2022 | 36347848 | PubTator, text mining | PubMed |
| Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics. | Front Endocrinol (Lausanne) | 2022 | 36339397 | PubTator, text mining | PubMed |
| Ketosis-prone diabetes mellitus: A phenotype that hospitalists need to understand. | World J Clin Cases | 2022 | 36338201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=36